104 related articles for article (PubMed ID: 17260902)
1. Instant solubilization of poorly water-soluble drugs by in-situ loading of aqueous phospholipid dispersions suitable for parenteral administration.
Van Hoogevest P; Rogue V; Brumec M; Schwebel H; Grunkemeyer JL; Leigh ML
PDA J Pharm Sci Technol; 2006; 60(6):366-77. PubMed ID: 17260902
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
Tiemessen H; van Hoogevest P; Leigh ML
Eur J Pharm Biopharm; 2004 Nov; 58(3):587-93. PubMed ID: 15451533
[TBL] [Abstract][Full Text] [Related]
3. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique.
Douroumis D; Fahr A
Eur J Pharm Biopharm; 2006 Jun; 63(2):173-5. PubMed ID: 16621482
[TBL] [Abstract][Full Text] [Related]
4. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
[TBL] [Abstract][Full Text] [Related]
5. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
6. Drug solubilization by complexation.
Loftsson T
Int J Pharm; 2017 Oct; 531(1):276-280. PubMed ID: 28842309
[TBL] [Abstract][Full Text] [Related]
7. Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution.
Young TJ; Johnson KP; Pace GW; Mishra AK
AAPS PharmSciTech; 2004 Feb; 5(1):E11. PubMed ID: 15198532
[TBL] [Abstract][Full Text] [Related]
8. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
Mohsin K; Long MA; Pouton CW
J Pharm Sci; 2009 Oct; 98(10):3582-95. PubMed ID: 19130605
[TBL] [Abstract][Full Text] [Related]
9. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
Kaukonen AM; Boyd BJ; Porter CJ; Charman WN
Pharm Res; 2004 Feb; 21(2):245-53. PubMed ID: 15032305
[TBL] [Abstract][Full Text] [Related]
10. Amorphous drug dispersions with mono- and diacyl lecithin: On molecular categorization of their feasibility and UV dissolution imaging.
Gautschi N; Van Hoogevest P; Kuentz M
Int J Pharm; 2015 Aug; 491(1-2):218-30. PubMed ID: 26129840
[TBL] [Abstract][Full Text] [Related]
11. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
12. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
[TBL] [Abstract][Full Text] [Related]
13. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
[TBL] [Abstract][Full Text] [Related]
14. Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine.
Rupp C; Steckel H; Müller BW
Int J Pharm; 2010 Aug; 395(1-2):272-80. PubMed ID: 20580793
[TBL] [Abstract][Full Text] [Related]
15. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
[TBL] [Abstract][Full Text] [Related]
16. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
[TBL] [Abstract][Full Text] [Related]
17. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
Yasuji T; Takeuchi H; Kawashima Y
Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
[TBL] [Abstract][Full Text] [Related]
18. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
19. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
Flaten GE; Skar M; Luthman K; Brandl M
Eur J Pharm Sci; 2007 Mar; 30(3-4):324-32. PubMed ID: 17204409
[TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
Buckley ST; Frank KJ; Fricker G; Brandl M
Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
